EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vitamin D in Type 2 Diabetes Mellitus According to Diabetic Kidney Disease Stage: What Is the Target in Clinical Practice?

João Soares Felício iD, Lícia Oliveira Ruivo iD, Inessa Silveira Bezerra iD, Maria Eduarda Nunes Avelar do Carmo iD, Isabel Jacob Fernandes iD, Beatriz Dias Lobo iD, Lilian de Souza D'Albuquerque Silva iD, Franciane Trindade Cunha de Melo iD, Ana Carolina Contente Braga de Souza iD, Natércia Neves Marques De Queiroz iD, Márcia Costa Dos Santos iD, Lorena Vilhena De Moraes iD und 11 weitere

Nutrients · 2026

DOI: 10.3390/nu18091408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von João Soares Felício und 22 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, University Hospital João de Barros Barreto, Federal University of Pará, Belem 66073-005, Brazil. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Nephropathies, Vitamin D, Vitamin D Deficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Low vitamin D (VD) has been associated with diabetic kidney disease (DKD). Nevertheless, VD normality concentrations remain under discussion.

Objectives

To evaluate VD concentrations in early and advanced DKD stages according to the Endocrine Society and Institute of Medicine standards in patients with type 2 diabetes mellitus (T2DM).

Methods

A cross-sectional study included 80 patients with T2DM and DKD in early (urine albumin–creatinine ratio (UACR) between 30 and 299 mg/g), group 1 (n = 29), and advanced stage (UACR ≥ 300 mg/g), group 2 (n = 51).

Results

Compared to group 1, patients in group 2 showed lower 25(OH)D concentrations (26.7 ± 10.1 vs. 30.2 ± 8.0 ng/mL; p ≤ 0.05). In group 2, when the serum VD concentrations were stratified according to the Endocrine Society, VD concentrations ≥ 30 ng/mL were associated with a considerably reduction in UACR compared with VD < 20 ng/mL (365.9 ± 268.3 vs. 937.6 ± 634 mg/g; p < 0.05), but not when compared to the range of 20–29.9 ng/mL (739.8 ± 1138 vs. 937.6 ± 634 mg/g; p = NS). Additionally, in this group, our regression model showed that each unit increase in VD was associated with a UACR reduction of 26.1 mg/g (R2 = 0.103; p < 0.05).

Conclusions

Higher vitamin D concentrations were associated with improved UACR only in clinical DKD, particularly when VD was at least 30 ng/mL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic NephropathiesVitamin DVitamin D DeficiencyHumansCross-Sectional StudiesFemaleMaleMiddle AgedAgedAlbuminuriaCreatinine

Stichwörter der Autor:innen

diabetes mellitusdiabetic kidney diseasetype 2 diabetes mellitusvitamin Dvitamin D standards

Substanzen

Vitamin DCreatinine

Autor:innen und Institutionen

  • Endocrinology Department, University Hospital João de Barros Barreto, Federal University of Pará, Belem 66073-005, Brazil.

ORCID-Profile: João Soares Felício, Lícia Oliveira Ruivo, Inessa Silveira Bezerra, Maria Eduarda Nunes Avelar do Carmo, Isabel Jacob Fernandes, Beatriz Dias Lobo, Lilian de Souza D'Albuquerque Silva, Franciane Trindade Cunha de Melo, Ana Carolina Contente Braga de Souza, Natércia Neves Marques De Queiroz, Márcia Costa Dos Santos, Lorena Vilhena De Moraes, Mayana Batista Barros, Alan Pinheiro Fernandes, Paula Gabriella Costa da Penha, Ana Clara Fleury da Fonseca Rodrigues, Pedro Paulo Freire Piani, Ana Regina Bastos Motta, Valéria Suênya Galvão Leal, Melissa de Sá Oliveira Dos Reis, Alyne Maciel Lobato, Karem Mileo Felício, Priscila Boaventura Barbosa De Figueiredo

Zitieren

APA

Felício, J. S., Ruivo, L. O., Bezerra, I. S., do Carmo, M. E. N. A., Fernandes, I. J., Lobo, B. D., Silva, L. S. D., de Melo, F. T. C., de Souza, A. C. C. B., De Queiroz, N. N. M., Dos Santos, M. C., De Moraes, L. V., Barros, M. B., Fernandes, A. P., da Penha, P. G. C., Rodrigues, A. C. F. D. F., Piani, P. P. F., Motta, A. R. B., Leal, V. S. G., …, & De Figueiredo, P. B. B. (2026). Vitamin D in Type 2 Diabetes Mellitus According to Diabetic Kidney Disease Stage: What Is the Target in Clinical Practice?. Nutrients. https://doi.org/10.3390/nu18091408

Vancouver

Felício JS, Ruivo LO, Bezerra IS, do Carmo MENA, Fernandes IJ, Lobo BD, et al. Vitamin D in Type 2 Diabetes Mellitus According to Diabetic Kidney Disease Stage: What Is the Target in Clinical Practice?. Nutrients. 2026. doi:10.3390/nu18091408

BibTeX
@article{Felcio2026,
  author = {Felício, João Soares and Ruivo, Lícia Oliveira and Bezerra, Inessa Silveira and do Carmo, Maria Eduarda Nunes Avelar and Fernandes, Isabel Jacob and Lobo, Beatriz Dias and Silva, Lilian de Souza D'Albuquerque and de Melo, Franciane Trindade Cunha and de Souza, Ana Carolina Contente Braga and De Queiroz, Natércia Neves Marques and Dos Santos, Márcia Costa and De Moraes, Lorena Vilhena and Barros, Mayana Batista and Fernandes, Alan Pinheiro and da Penha, Paula Gabriella Costa and Rodrigues, Ana Clara Fleury da Fonseca and Piani, Pedro Paulo Freire and Motta, Ana Regina Bastos and Leal, Valéria Suênya Galvão and Dos Reis, Melissa de Sá Oliveira and Lobato, Alyne Maciel and Felício, Karem Mileo and De Figueiredo, Priscila Boaventura Barbosa},
  title = {Vitamin D in Type 2 Diabetes Mellitus According to Diabetic Kidney Disease Stage: What Is the Target in Clinical Practice?},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18091408}
}
Kostenlos starten →